Abeona Therapeutics (ABEO) Cost of Revenue (2020 - 2025)
Historic Cost of Revenue for Abeona Therapeutics (ABEO) over the last 8 years, with Q3 2025 value amounting to $488000.0.
- Abeona Therapeutics' Cost of Revenue changed N/A to $488000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $618000.0, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2023, which is 25666.67% up from last year.
- According to the latest figures from Q3 2025, Abeona Therapeutics' Cost of Revenue is $488000.0.
- In the past 5 years, Abeona Therapeutics' Cost of Revenue ranged from a high of $32.9 million in Q1 2021 and a low of $30000.0 during Q3 2023
- Its 4-year average for Cost of Revenue is $5.1 million, with a median of $350000.0 in 2022.
- Per our database at Business Quant, Abeona Therapeutics' Cost of Revenue changed by 0.0% in 2021 and then soared by 35000.0% in 2023.
- Quarter analysis of 4 years shows Abeona Therapeutics' Cost of Revenue stood at $32.9 million in 2021, then tumbled by 99.7% to $100000.0 in 2022, then crashed by 70.0% to $30000.0 in 2023, then soared by 1526.67% to $488000.0 in 2025.
- Its Cost of Revenue was $488000.0 in Q3 2025, compared to $100000.0 in Q2 2025 and $30000.0 in Q3 2023.